Drug search by name

Recombivax HB Pediatric/Adolescent and Low birth weight

Result of checking the interaction of drug Recombivax HB Pediatric/Adolescent and disease Low birth weight for safety when used together.

Check result:

Recombivax HB Pediatric/Adolescent <> Low birth weight

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hepatitis B vaccine should be deferred for infants with a birth weight less than 2,000 grams if the mother is documented to be HBsAg negative at the time of the infant's birth. If the mother is HBsAg positive (or the status cannot be determined), the infant should receive the vaccine within 12 hours after birth.
Apnea following intramuscular vaccination has been observed in some infants born prematurely and the decision to administer any intramuscular vaccine, including hepatitis B vaccine, should be based on consideration of the infant's medical status, and the potential benefits and risks of vaccination. Close monitoring is recommended.

Recombivax HB Pediatric/Adolescent

Generic Name: hepatitis b pediatric vaccine

Brand Name: Engerix-B Pediatric, Recombivax HB Pediatric/Adolescent, Recombivax HB

Synonyms: n.a.

What is Recombivax HB Pediatric/Adolescent?